246 related articles for article (PubMed ID: 27071335)
1. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.
McConnell HL; Schwartz DL; Richardson BE; Woltjer RL; Muldoon LL; Neuwelt EA
Nanomedicine; 2016 Aug; 12(6):1535-42. PubMed ID: 27071335
[TBL] [Abstract][Full Text] [Related]
2. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
[TBL] [Abstract][Full Text] [Related]
3. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
[TBL] [Abstract][Full Text] [Related]
5. Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice.
Doyle KP; Quach LN; Arceuil HE; Buckwalter MS
Neurosci Lett; 2015 Jan; 584():236-40. PubMed ID: 25449870
[TBL] [Abstract][Full Text] [Related]
6. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
7. Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.
Barajas RF; Hamilton BE; Schwartz D; McConnell HL; Pettersson DR; Horvath A; Szidonya L; Varallyay CG; Firkins J; Jaboin JJ; Kubicky CD; Raslan AM; Dogan A; Cetas JS; Ciporen J; Han SJ; Ambady P; Muldoon LL; Woltjer R; Rooney WD; Neuwelt EA
Neuro Oncol; 2019 Mar; 21(4):517-526. PubMed ID: 30277536
[TBL] [Abstract][Full Text] [Related]
8. Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.
Ariza de Schellenberger A; Poller WC; Stangl V; Landmesser U; Schellenberger E
Int J Nanomedicine; 2018; 13():7905-7913. PubMed ID: 30538467
[TBL] [Abstract][Full Text] [Related]
9. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
Deh K; Zaman M; Vedvyas Y; Liu Z; Gillen KM; O' Malley P; Bedretdinova D; Nguyen T; Lee R; Spincemaille P; Kim J; Wang Y; Jin MM
Sci Rep; 2020 Jan; 10(1):1171. PubMed ID: 31980695
[TBL] [Abstract][Full Text] [Related]
10. Emerging applications for ferumoxytol as a contrast agent in MRI.
Bashir MR; Bhatti L; Marin D; Nelson RC
J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
[TBL] [Abstract][Full Text] [Related]
11. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: proof of concept study.
Hedgire S; Krebill C; Wojtkiewicz GR; Oliveira I; Ghoshhajra BB; Hoffmann U; Harisinghani MG
Br J Radiol; 2018 Dec; 91(1092):20180461. PubMed ID: 30160173
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of islet magnetic resonance imaging using ferumoxytol in intraportal islet transplantation.
Jin SM; Oh SH; Oh BJ; Shim W; Choi JM; Yoo D; Hwang YH; Lee JH; Lee DY; Kim JH
Biomaterials; 2015 Jun; 52():272-80. PubMed ID: 25818433
[TBL] [Abstract][Full Text] [Related]
14. USPIO-Enhanced MRI Neuroimaging: A Review.
Gkagkanasiou M; Ploussi A; Gazouli M; Efstathopoulos EP
J Neuroimaging; 2016; 26(2):161-8. PubMed ID: 26932522
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.
Dósa E; Guillaume DJ; Haluska M; Lacy CA; Hamilton BE; Njus JM; Rooney WD; Kraemer DF; Muldoon LL; Neuwelt EA
Neuro Oncol; 2011 Feb; 13(2):251-60. PubMed ID: 21163809
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall Superparamagnetic Iron Oxide Imaging Identifies Tissue and Nerve Inflammation in Pain Conditions.
Shen S; Ding W; Ahmed S; Hu R; Opalacz A; Roth S; You Z; Wotjkiewicz GR; Lim G; Chen L; Mao J; Chen JW; Zhang Y
Pain Med; 2018 Apr; 19(4):686-692. PubMed ID: 29177411
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
[TBL] [Abstract][Full Text] [Related]
19. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.
Daldrup-Link HE; Theruvath AJ; Rashidi A; Iv M; Majzner RG; Spunt SL; Goodman S; Moseley M
Pediatr Radiol; 2022 Feb; 52(2):354-366. PubMed ID: 34046709
[TBL] [Abstract][Full Text] [Related]
20. Impact of ferumoxytol magnetic resonance imaging on the rhesus macaque maternal-fetal interface†.
Nguyen SM; Wiepz GJ; Schotzko M; Simmons HA; Mejia A; Ludwig KD; Zhu A; Brunner K; Hernando D; Reeder SB; Wieben O; Johnson K; Shah D; Golos TG
Biol Reprod; 2020 Feb; 102(2):434-444. PubMed ID: 31511859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
